Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
Published version of a preprint
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Methods: Samples from symptomatic patients are processed by SpotMalaria, a high-throughput system that produces a comprehensive set of genotypes comprising several drug resistance markers, species markers and a genomic barcode. GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions used to map prevalence of resistance to multiple drugs. Results: GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces, informing decision-making by NMCPs. Conclusions: GenRe-Mekong provides detailed knowledge about drug resistance at a local level, and facilitates data sharing at a regional level, enabling cross-border resistance monitoring and providing the public health community with valuable insights. The project provides a rich open data resource to benefit the entire malaria community. Funding: The GenRe-Mekong project is funded by the Bill and Melinda Gates Foundation (OPP11188166, OPP1204268). Genotyping and sequencing were funded by the Wellcome Trust (098051, 206194, 203141, 090770, 204911, 106698/B/14/Z) and Medical Research Council (G0600718). A proportion of samples were collected with the support of the UK Department for International Development (201900, M006212), and Intramural Research Program of the National Institute of Allergy and Infectious Diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High-throughput genotyping offers a more operationally feasible approach that can be applied to low-volume samples such as dried blood spots and would be more readily implemented in surveillance frameworks in malaria-endemic countries17–20.”
From Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites (2024) · cites this paper as [17]
In the citing paper
“this methodology is widely used in the malaria community and has demonstrated utility and feasibility for malaria molecular surveillance in low- and middle-income countries17.”
From Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites (2024) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · cited 1×
“This results in high parasite exposure to drugs, which may be a major evolutionary driving force for the emergence of genetic factors that confer resistance to frontline therapies (Escalante et al., 2009).”
BackgroundSelf-citationSpread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205 · cited 3×
“Hence, in view of the emergence in the GMS of parasite strains resistant to artemisinin (Dondorp et al., 2009; Ashley et al., 2014; MalariaGEN Plasmodium falciparum Community Project, 2016) and its ACT partner drug piperaquine, (Amaratunga et al., 2016; van der Pluijm et al., 2019; Leang et al.,…”
BackgroundMethodSelf-citationHay, S. I., Rogers, D. J., Toomer, J. F., & Snow, R. W. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90246-3 · Cited by 312
Malaria in the Greater Mekong Subregion: heterogeneity and complexity.
Cui, L., Yan, G., Sattabongkot, J., Cao, Y., Chen, B., Chen, X., Fan, Q., Fang, Q., Jongwutiwes, S., Parker, D., et al. (2012) · Acta Tropica · doi:10.1016/j.actatropica.2011.02.016 · Cited by 277 · cited 1×
“Infections are most common amongst individuals who work in or live near forests in remote rural parts of the region (Cui et al., 2012).”
BackgroundSelf-citation
Research works printed but not linked: 39
- Agrawal, 2017, Association of a novel mutation in the Plasmodium falciparum chloroquine resistance transporter with decreased piperaquine sensitivity, The Journal of Infectious Diseases, 216, 468, 10.1093/infdis/jix334 · DOI
- Amaratunga, 2016, Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study, The Lancet Infectious Diseases, 16, 357, 10.1016/S1473-3099(15)00487-9 · DOI · Paper page
- Amato, 2017, Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study, The Lancet Infectious Diseases, 17, 164, 10.1016/S1473-3099(16)30409-1 · DOI · Paper page
- Amato, 2018, Origins of the current outbreak of multidrug-resistant malaria in Southeast Asia: a retrospective genetic study, The Lancet Infectious Diseases, 18, 337, 10.1016/S1473-3099(18)30068-9 · DOI · Paper page
- Ariey, 2014, A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, 505, 50, 10.1038/nature12876 · DOI · Paper page
- Artimovich, 2015, Persistence of Sulfadoxine-Pyrimethamine resistance despite reduction of drug pressure in Malawi, Journal of Infectious Diseases, 212, 694, 10.1093/infdis/jiv078 · DOI
- Chang, 2019, Mapping imported malaria in Bangladesh using parasite genetic and human mobility data, eLife, 8, 10.7554/eLife.43481 · DOI · Paper page
- Chaumeau, 2018, Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages, Wellcome Open Research, 3, 10.12688/wellcomeopenres.14761.1 · DOI
- Daniels, 2015, Modeling malaria genomics reveals transmission decline and rebound in Senegal, PNAS, 112, 7067, 10.1073/pnas.1505691112 · DOI · Paper page
- Desmond-Hellmann, 2016, Progress lies in precision, Science, 353, 10.1126/science.aai7598 · DOI
- Directorate of National Vector Borne Disease Control Programme DGoHS, Government of India. 2013. Ministry of Health and Family Welfare. National Drug Policy on Malaria.
- Escalante, 2009, The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum, Trends in Parasitology, 25, 557, 10.1016/j.pt.2009.09.008 · DOI
- Felger, 2020, PCR correction strategies for malaria drug trials: updates and clarifications, The Lancet Infectious Diseases, 20, e20, 10.1016/S1473-3099(19)30426-8 · doi:10.1016/s1473-3099(19)30426-8
- Frosch, 2014, Return of widespread Chloroquine-Sensitive Plasmodium falciparum to Malawi, The Journal of Infectious Diseases, 210, 1110, 10.1093/infdis/jiu216 · doi:10.1093/infdis/jiu216
- Hamilton, 2019, Evolution and expansion of multidrug-resistant malaria in Southeast Asia: a genomic epidemiology study, The Lancet Infectious Diseases, 19, 943, 10.1016/S1473-3099(19)30392-5 · DOI · Paper page
- Landier, 2018, Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme, The Lancet, 391, 1916, 10.1016/S0140-6736(18)30792-X · DOI · Paper page
- Laufer, 2006, Return of chloroquine antimalarial efficacy in Malawi, New England Journal of Medicine, 355, 1959, 10.1056/NEJMoa062032 · DOI · Paper page
- Leang, 2015, Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine Open-Label multicenter clinical assessment, Antimicrobial Agents and Chemotherapy, 59, 4719, 10.1128/AAC.00835-15 · DOI · Paper page
- Lim, 2013, Ex vivo Susceptibility of Plasmodium falciparum to Antimalarial Drugs in Western, Northern, and Eastern Cambodia, 2011-2012: Association with Molecular Markers, Antimicrobial Agents and Chemotherapy, 57, 5277, 10.1128/AAC.00687-13 · DOI
- MalariaGEN Plasmodium falciparum Community Project, 2016, Genomic epidemiology of artemisinin resistant malaria, eLife, 5, 10.7554/eLife.08714 · DOI · Paper page
- Ménard, 2016, A worldwide map of Plasmodium falciparum K13-Propeller Polymorphisms, New England Journal of Medicine, 374, 2453, 10.1056/NEJMoa1513137 · DOI · Paper page
- Miotto, 2013, Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia, Nature Genetics, 45, 648, 10.1038/ng.2624 · DOI · Paper page
- Miotto, 2015, Genetic architecture of artemisinin-resistant Plasmodium falciparum, Nature Genetics, 47, 226, 10.1038/ng.3189 · DOI · Paper page
- Mita, 2009, Spread and evolution of Plasmodium falciparum drug resistance, Parasitology International, 58, 201, 10.1016/j.parint.2009.04.004 · DOI · Paper page
- Mita, 2011, Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations, The Journal of Infectious Diseases, 204, 1980, 10.1093/infdis/jir664 · DOI
- Nagar, 2019, Population pharmacogenomics for precision public health in Colombia, Frontiers in Genetics, 10, 10.3389/fgene.2019.00241 · DOI
- Noedl, 2008, Evidence of Artemisinin-Resistant malaria in western Cambodia, New England Journal of Medicine, 359, 2619, 10.1056/NEJMc0805011 · DOI · Paper page
- Oyola, 2016, Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification, Malaria Journal, 15, 10.1186/s12936-016-1641-7 · doi:10.1186/s12936-016-1641-7
- Pearson, 2019, An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples, 10.1101/824730 · DOI
- Plowe, 2009, The evolution of drug-resistant malaria, Transactions of the Royal Society of Tropical Medicine and Hygiene, 103, S11, 10.1016/j.trstmh.2008.11.002 · DOI
- Roper, 2004, Intercontinental spread of pyrimethamine-resistant malaria, Science, 305, 10.1126/science.1098876 · DOI · Paper page
- Ross, 2018, Emerging southeast asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine, Nature Communications, 9, 10.1038/s41467-018-05652-0 · DOI · Paper page
- Spring, 2015, Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study, The Lancet Infectious Diseases, 15, 683, 10.1016/S1473-3099(15)70049-6 · DOI · Paper page
- Takala-Harrison, 2015, Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia, The Journal of Infectious Diseases, 211, 670, 10.1093/infdis/jiu491 · DOI · Paper page
- Trape, 1998, Impact of chloroquine resistance on malaria mortality, Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie, 321, 689, 10.1016/S0764-4469(98)80009-7 · DOI · Paper page
- van der Pluijm, 2019, Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study, The Lancet Infectious Diseases, 19, 952, 10.1016/S1473-3099(19)30391-3 · DOI · Paper page
- von Seidlein, 2019, The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial, PLOS Medicine, 16, 10.1371/journal.pmed.1002745 · DOI · Paper page
- World Health Organization, 2017, Update on Artemisinin Resistance
- World Health Organization. 2018. Geneva: World Health Organization. Status Report on Artemisinin Resistance and ACT Efficacy.
Cited by
Siegel, S. V., Trimarsanto, H., Amato, R., Murie, K., Taylor, A. R., Sutanto, E., Kleinecke, M., Whitton, G., Watson, J. A., Imwong, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51015-3 · Cited by 30
Self-citationNayak, S., Peto, T. J., Kucharski, M., Tripura, R., Callery, J. J., Quang Huy, D. T., Gendrot, M., Lek, D., Nghia, H. D. T., van der Pluijm, R. W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54915-6 · Cited by 15
Self-citationDegaga, T. S., Sime, H., Ruybal-Pesántez, S., Osborne, A., Mwaura, M., Bamboro, S. A., Mnjala, H., Mekonnen, G., Ermias, S., Fantahun, A., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-06050-4 · Cited by 1
Metadata
- Authors
- Jacob, C. G., Thuy-Nhien, N., Mayxay, M., Maude, R. J., Quang, H. H., Hongvanthong, B., Vanisaveth, V., Ngo Duc, T., Rekol, H., van der Pluijm, R., von Seidlein, L., Fairhurst, R., Nosten, F., Hossain, M. A., Park, N., Goodwin, S., Ringwald, P., Chindavongsa, K., Newton, P., Ashley, E., Phalivong, S., Maude, R., Leang, R., Huch, C., Dong, L. T., Nguyen, K.-T., Nhat, T. M., Hien, T. T., Nguyen, H., Zdrojewski, N., Canavati, S., Sayeed, A. A., Uddin, D., Buckee, C., Fanello, C. I., Onyamboko, M., Peto, T., Tripura, R., Amaratunga, C., Myint Thu, A., Delmas, G., Landier, J., Parker, D. M., Chau, N. H., Lek, D., Suon, S., Callery, J., Jittamala, P., Hanboonkunupakarn, B., Pukrittayakamee, S., Phyo, A. P., Smithuis, F., Lin, K., Thant, M., Hlaing, T. M., Satpathi, P., Satpathi, S., Behera, P. K., Tripura, A., Baidya, S., Valecha, N., Anvikar, A. R., Ul Islam, A., Faiz, A., Kunasol, C., Drury, E., Kekre, M., Ali, M., Love, K., Rajatileka, S., Jeffreys, A. E., Rowlands, K., Hubbart, C. S., Dhorda, M., Vongpromek, R., Kotanan, N., Wongnak, P., Almagro Garcia, J., Pearson, R. D., Ariani, C. V., Chookajorn, T., Malangone, C., Nguyen, T., Stalker, J., Jeffery, B., Keatley, J., Johnson, K. J., Muddyman, D., Chan, X. H. S., Sillitoe, J., Amato, R., Simpson, V., Gonçalves, S., Rockett, K., Day, N. P., Dondorp, A. M., Kwiatkowski, D. P., & Miotto, O.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2021-08-10
- Volume
- 10
- ISSN
- 2050-084X
- Cited by
- 110
- References
- 4
- Language
- en
- Licence
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- creativecommons.org/publicdomain/zero/1.0/ (am)
- creativecommons.org/publicdomain/zero/1.0/ (tdm)
- Funders
- Bill and Melinda Gates Foundation (OPP11188166, OPP1204268)
- Wellcome Trust (098051, 206194, 203141, 090770, 204911, 106698/B/14/Z)
- Medical Research Council (G0600718)
- Department for International Development, UK Government (201900, M006212)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. https://app.cochat.ai/papers/10.7554/elife.62997
- The paper
- Jacob, C. G., Thuy-Nhien, N., Mayxay, M., Maude, R. J., Quang, H. H., Hongvanthong, B., Vanisaveth, V., Ngo Duc, T., Rekol, H., van der Pluijm, R., von Seidlein, L., Fairhurst, R., Nosten, F., Hossain, M. A., Park, N., Goodwin, S., Ringwald, P., Chindavongsa, K., Newton, P., . . . Miotto, O. (2021). Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. eLife. https://doi.org/10.7554/elife.62997
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.